Viewing Study NCT06254560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-05-15 @ 6:07 PM
Study NCT ID: NCT06254560
Status: RECRUITING
Last Update Posted: 2024-02-12
First Post: 2024-01-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Severe Aplastic Anemia View
None Platelet Transfusion Refractoriness View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Severe aplastic anemia View
None Platelet transfusion refractoriness View
None Rituximab View